Page last updated: 2024-08-26

cobalt and glyburide

cobalt has been researched along with glyburide in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19901 (14.29)18.7374
1990's2 (28.57)18.2507
2000's3 (42.86)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bosco, D; Chanson, M; Giordano, E; Meda, P; Soria, B1
Matthews, EK; Shotton, PA1
Kojima, I; Miyazaki, J; Mogami, H; Nobusawa, R; Ohnota, H; Satou, F; Shibata, H1
Dohi, Y; Itoh, T; Ohashi, M1
Bloomquist, JR; Klorig, DC; Kou, J1
Arayne, MS; Farooq, A; Sultana, N; Zaman, MK1
Fei, F; Li, L; Luo, L; Qu, Y; Rong, Z1

Other Studies

7 other study(ies) available for cobalt and glyburide

ArticleYear
Ion channels of glucose-responsive and -unresponsive beta-cells.
    Diabetes, 1991, Volume: 40, Issue:8

    Topics: Animals; Cobalt; Electrophysiology; Glucose; Glyburide; Hemolytic Plaque Technique; In Vitro Techniques; Ion Channels; Islets of Langerhans; Male; Membrane Potentials; Potassium Channels; Potassium Chloride; Rats; Rats, Inbred Strains; Sodium Channels; Tolbutamide

1991
The control of 86Rb efflux from rat isolated pancreatic islets by the sulphonylureas tolbutamide and glibenclamide.
    British journal of pharmacology, 1984, Volume: 82, Issue:3

    Topics: Animals; Biological Transport; Calcium; Cell Membrane; Cell Membrane Permeability; Cobalt; Glyburide; In Vitro Techniques; Islets of Langerhans; Male; Potassium; Radioisotopes; Rats; Rats, Inbred Strains; Rubidium; Tolbutamide

1984
Inhibition of ATP-sensitive K+ channel by a non-sulfonylurea compound KAD-1229 in a pancreatic beta-cell line, MIN 6 cell.
    European journal of pharmacology, 1994, Nov-15, Volume: 269, Issue:3

    Topics: Action Potentials; Adenosine Triphosphate; Binding, Competitive; Calcium; Cell Membrane; Cobalt; Dose-Response Relationship, Drug; Drug Synergism; Fura-2; Glucose; Glyburide; Humans; Hypoglycemic Agents; Indoles; Insulin; Insulin Secretion; Insulinoma; Islets of Langerhans; Isoindoles; Membrane Potentials; Nifedipine; Pancreatic Neoplasms; Patch-Clamp Techniques; Potassium Channel Blockers; Tumor Cells, Cultured

1994
Possible mechanisms underlying the vasodilatation induced by olprinone, a phosphodiesterase III inhibitor, in rabbit coronary artery.
    British journal of pharmacology, 2000, Volume: 129, Issue:5

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Acetylcholine; Animals; Cobalt; Coronary Vessels; Cyclic Nucleotide Phosphodiesterases, Type 3; Electrophysiology; Glyburide; Hypoglycemic Agents; Imidazoles; In Vitro Techniques; Isometric Contraction; Male; Membrane Potentials; Muscle, Smooth, Vascular; Nitrobenzoates; Phosphodiesterase Inhibitors; Potassium; Potassium Channel Blockers; Pyridones; Rabbits; Sodium; Vascular Resistance; Vasodilation

2000
Potentiating effect of the ATP-sensitive potassium channel blocker glibenclamide on complex I inhibitor neurotoxicity in vitro and in vivo.
    Neurotoxicology, 2006, Volume: 27, Issue:5

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adenosine Triphosphate; Animals; Blotting, Western; Calcium; Cobalt; Dopamine; Dose-Response Relationship, Drug; Drug Synergism; Electron Transport Complex I; Glyburide; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Neurotoxicity Syndromes; Potassium Channel Blockers; Rotenone; Tyrosine 3-Monooxygenase

2006
Synthesis and characterization of glibenclamide complexes of magnesium, chromium, cobalt, nickel, zinc and cadmium salts.
    Pakistan journal of pharmaceutical sciences, 2006, Volume: 19, Issue:2

    Topics: Cadmium Chloride; Chlorides; Chromium Compounds; Cobalt; Glyburide; Hypoglycemic Agents; Magnesium Chloride; Magnetic Resonance Spectroscopy; Metals; Nickel; Spectrophotometry, Atomic; Spectrophotometry, Infrared; Transition Temperature; Zinc Compounds

2006
Combined treatment of glibenclamide and CoCl2 decreases MMP9 expression and inhibits growth in highly metastatic breast cancer.
    Journal of experimental & clinical cancer research : CR, 2013, May-28, Volume: 32

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cobalt; Female; Gene Expression Regulation, Neoplastic; Glyburide; Humans; Matrix Metalloproteinase 9; Mice; Neoplasm Metastasis; Proliferating Cell Nuclear Antigen; RNA, Messenger; Tumor Burden

2013